MAR
68
-3
MU
66
10
NVDA
49
3
PRU
60
-2
AME
66
4
NOV
48
-4
PAYX
32
-4
CF
44
-4
DGX
33
-3
JBHT
63
3
MUR
33
-5
DTE
40
4
PCAR
62
-2
MAC
67
2
PPL
55
3
AN
43
-6
MNST
55
3
AMP
66
-3
NRG
44
7
FOX
64
2
MAR
68
-3
MU
66
10
NVDA
49
3
PRU
60
-2
AME
66
4
NOV
48
-4
PAYX
32
-4
CF
44
-4
DGX
33
-3
JBHT
63
3
MUR
33
-5
DTE
40
4
PCAR
62
-2
MAC
67
2
PPL
55
3
AN
43
-6
MNST
55
3
AMP
66
-3
NRG
44
7
FOX
64
2
Financhill
Back

CrossingBridge Pre-Merger SPAC ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison

Sell
20

SPC
CrossingBridge Pre-Merger SPAC ETF

Last Price:
$21.55
Seasonality Move:
-1.19%
Sell
45

DRUG
Bright Minds Biosciences, Inc.

Last Price:
$83.03
Seasonality Move:
-32.16%
Sell
20
CrossingBridge Pre-Merger SPAC ETF (SPC) is a Sell

Is CrossingBridge Pre-Merger SPAC ETF a Buy, Sell or Hold?

  • The current CrossingBridge Pre-Merger SPAC ETF [SPC] share price is $21.75. The Score for SPC is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • SPC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
45
Bright Minds Biosciences, Inc. (DRUG) is a Sell

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

  • The current Bright Minds Biosciences, Inc. [DRUG] share price is $78.88. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SPC Stock Price Chart

What is CrossingBridge Pre-Merger SPAC ETF's stock price today?

  • The CrossingBridge Pre-Merger SPAC ETF share price today is $21.75
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPC is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

  • The Bright Minds Biosciences, Inc. share price today is $78.88
    The current trend is moderately bullish and DRUG is experiencing selling pressure, which indicates risk of future bearish movement.

SPC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.06 Buy
Relative Strength Index (14 RSI): 50.93 Buy
Chaikin Money Flow: 14311 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.59 - 21.95) Sell
Bollinger Bands (100): (21.53 - 21.89) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.94 Buy
Relative Strength Index (14 RSI): 54.75 Buy
Chaikin Money Flow: -145421 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (60.39 - 83.51) Buy
Bollinger Bands (100): (41.65 - 69.37) Buy

SPC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.59 Buy
20-day SMA: 21.73 Buy
50-day SMA: 21.83 Sell
200-day SMA: 21.42 Buy
8-day EMA: 8.56 Buy
20-day EMA: 3.93 Buy
50-day EMA: 1.66 Buy
200-day EMA: 0.43 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 85.2 Sell
20-day SMA: 75.43 Buy
50-day SMA: 66.05 Buy
200-day SMA: 43.03 Buy
8-day EMA: 83.79 Sell
20-day EMA: 77.26 Buy
50-day EMA: 67.4 Buy
200-day EMA: 47.62 Buy

CrossingBridge Pre-Merger SPAC ETF Earnings Growth & SPC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.

CrossingBridge Pre-Merger SPAC ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):